**Author details**

Stavros Hatzopoulos1\*, Andrea Ciorba<sup>1</sup> , Virginia Corazzi<sup>1</sup> and Piotr Henryk Skarzynski2, 3, 4

\*Address all correspondence to: sdh1@unife.it

1 ENT & Audiology Department, University Hospital of Ferrara, Ferrara, Italy

2 World Hearing Center, Warsaw, Poland

3 Department of Heart Failure and Cardiac Rehabilitation, Medical University of Warsaw, Warsaw, Poland

4 Institute of Sensory Organs, Kajetany, Poland

## **References**

[1] Kemp DT. Stimulated acoustic emissions from within the human auditory system. *J Acoust Soc Am* 1978;64(5):1386-1391.

[2] Kemp DT. The evoked cochlear mechanical response and the auditory microstructure – evidence for a new element in cochlear mechanics. *Scand Audiol Suppl* 1979;(9):35-47.

**6. Conclusions**

144 Up to Date on Meniere's Disease

**Acknowledgements**

**Author details**

Warsaw, Poland

**References**

within the STRATEGMED program.

Stavros Hatzopoulos1\*, Andrea Ciorba<sup>1</sup>

\*Address all correspondence to: sdh1@unife.it

4 Institute of Sensory Organs, Kajetany, Poland

*Acoust Soc Am* 1978;64(5):1386-1391.

2 World Hearing Center, Warsaw, Poland

The data in the literature suggest that OAEs represent a valid noninvasive instrument, which can monitor the cochlear damage entity in patients affected by MD, and could also monitor its progress. OAEs are not just reliable tools, but they are a low-cost methodology in comparison

The data in the literature shows that alterations in the inner ear caused by the presence of a hydrops can be monitored accurately with OAEs. Glycerol results can also be monitored successfully. Some reports suggest that a DPOAE protocol can be more suitable for MD monitoring tasks, but considering the mechanisms of OAE generation this might not be true. TEOAEs and DPOAEs can similarly detect inner ear alterations as long as these affect the basilar mem-

Although promising, this field of research still needs to be expanded, where experimental studies are lacking. It is likely that in the future, either implementing our knowledge among MD, or implementing the OAE technology, the application of the OAE for patients affected by MD could be further expanded and offered with more information to the clinical practice.

This work was supported by the project "Integrated system of tools for diagnostics and telerehabilitation of sensory organs disorders (hearing, vision, speech, balance, taste, smell)" acr. INNOSNESE, co-financed by the National Centre for Research and Development (Poland),

, Virginia Corazzi<sup>1</sup>

3 Department of Heart Failure and Cardiac Rehabilitation, Medical University of Warsaw,

[1] Kemp DT. Stimulated acoustic emissions from within the human auditory system. *J* 

1 ENT & Audiology Department, University Hospital of Ferrara, Ferrara, Italy

and Piotr Henryk Skarzynski2, 3, 4

to standardized MD monitoring methods, such as electrocochleography.

brane mobility and the functioning of outer hair cells.


[36] van Huffelen WM, Mateijsen NJ, Wit HP. Classification of patients with Meniere's disease using otoacoustic emissions. *Audiol Neurotol* 1998;3(6):419-430.

[19] Jablonka-Strom A, Pospiech L, Zatonski M, Bochnia M. Dynamics of pure tone audiometry and DPOAE changes induced by glycerol in Meniere's disease. *Eur Arch* 

[20] Basel T, Lutkenhoner B. Auditory threshold shifts after glycerol administration to patients with suspected Meniere's disease: a retrospective analysis. *Ear Hear* 2013;34(3):370-384.

[22] Friberg L, Stahle J, Svedberg A. The natural course of Ménière's disease. *Acta Otolaryngol* 

[23] Horst JW, De Kleine E. Audiogram fine structure and spontaneous otoacoustic emis-

[25] Harris FP, Probst R. Transiently evoked otoacoustic emissions in patients with Meniere's

[26] van Huffelen WM, Mateijsen DJM, Wit HP. Classification of patient with Meniere's dis-

[27] Avan P, Durrant JD, Buki B. Possible effects of cochlear hydrops and related phenomena

[28] Avan P, Giraudet F, Chauveau B, Gilain L, Mom T. Unstable distortion-product oto-

[29] de Kleine E, Mateijsen DJM, Wit HP, Albers FWJ. Evoked otoacoustic emissions in

[30] Eggermont JJ, Schmidt PH. Meniere's disease: a long-term follow-up study of hearing

[31] Brown DJ, Gibson WP. On the differential diagnosis of Ménière's disease using lowfrequency acoustic biasing of the 2f1-f2 DPOAE. *Hear Res* 2011;282(1-2):119-127.

[32] Martin GK, Ohlms LA, Franklin DJ, Harris FP, Lonsbury-Martin BL. Distortion Product Emission in Humans: Influence of sensorineural hearing loss. *Ann Otol Rhinol Laryngol*

[33] Dauman R, Aran JM, Portmann M. Summating potential and water balance in Meniere's

[34] Buki B, Avan P, Lemaire JJ, Dordain M, Chazal J, Ribari O. Otoacoustic emissions: a new tool for monitoring intracranial pressure changes through stapes displacements. *Hear* 

[35] Rotter A, Weikert S, Hensel J, Scholz G, Scherer H, Holzl M. Low-frequency distortion product otoacoustic emission test compared to ECoG in diagnosing endolymphatic

acoustic emission phase in Meniere's disease. *Hear Res* 2011;277(1-2) :88-95.

[24] Hamann KF, Arnold W. Meniere's disease. *Adv Otorhinolaryngol* 1999;55:137-168.

[21] Morrison AW. Predictive tests for Meniere's disease. *Am J Otol* 1986;7:5-10.

sions in patients with Meniere's disease. *Audiology* 1999;38:267-270.

ease using otoacoustic emissions. *Audiol Neurootol* 1998;3:419-430.

patients with Ménière's disease. *Otol Neurotol* 2002;23(4):510-516.

disease. *Acta Otolaryngol (Stockh)* 1992;112:36-44.

on OAEs. *Sem Hear* 2001;22:405-414.

loss. *Ann Otol Rhinol Laryngol* 1985;94:1-9.

disease. *Ann Otol Rhinol Laryngol* 1986;95:389-395

hydrops. *Eur Arch Otorhinolaryngol* 2008;265(6):643-649.

1990;99(suppl):30-42.

*Res* 1996;94(1-2):125-139

*Otorhinolaryngol* 2013;270(5):1751-1756.

*(Stockh)* 1984;406(suppl):72-77.

146 Up to Date on Meniere's Disease

